Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Emerging role of the apelin system in cardiovascular homeostasis BIOMARKERS IN MEDICINE Chong, K. S., Gardner, R. S., Ashley, E. A., Dargie, H. J., McDonagh, T. A. 2007; 1 (1): 37-43

Abstract

The angiotensin receptor-like 1 (APJ) and its novel ligand, apelin, share similarities in structure and anatomical distribution with that of angiotensin II and the angiotensin II type 1 receptor. However, apelin has positive inotropic, vasodilatory and diuretic properties. Differential expression and synthesis of apelin and the APJ receptor in normal and failing hearts suggest that the apelin system may contribute to the pathophysiology of human heart failure and has potential therapeutic use in treatment of heart failure.

View details for DOI 10.2217/17520363.1.1.37

View details for Web of Science ID 000252123800012

View details for PubMedID 20477459